Category: Pediatric dermatology

Affecting up to 5% of infants, infantile hemangiomas are the most common benign tumors of infancy. The discovery of propranolol's effectiveness in 2008 revolutionized treatment, leading to the key question: **why propranolol for hemangiomas?**

Infantile hemangiomas (IH) are the most common vascular tumors in infants. As a treatment, topical timolol has emerged as a leading option. Understanding how to use timolol for hemangioma is key for caregivers seeking a safe and effective solution for superficial lesions.

Infantile hemangiomas (IH) are the most common pediatric tumor, affecting approximately 5% of newborns [1.8.1, 1.8.6]. This article explores a key treatment question: How quickly does timolol work for hemangioma?

Infantile hemangiomas are the most common vascular tumors of infancy, affecting 4% to 5% of babies. This article explains how to apply timolol drops to hemangioma, a common off-label treatment prescribed by doctors.